1. Home
  2. LC vs WVE Comparison

LC vs WVE Comparison

Compare LC & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LC
  • WVE
  • Stock Information
  • Founded
  • LC 2006
  • WVE 2012
  • Country
  • LC United States
  • WVE Singapore
  • Employees
  • LC N/A
  • WVE N/A
  • Industry
  • LC Finance: Consumer Services
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • LC Finance
  • WVE Health Care
  • Exchange
  • LC Nasdaq
  • WVE Nasdaq
  • Market Cap
  • LC 1.0B
  • WVE 915.6M
  • IPO Year
  • LC 2014
  • WVE 2015
  • Fundamental
  • Price
  • LC $11.00
  • WVE $6.57
  • Analyst Decision
  • LC Strong Buy
  • WVE Strong Buy
  • Analyst Count
  • LC 7
  • WVE 12
  • Target Price
  • LC $16.29
  • WVE $20.33
  • AVG Volume (30 Days)
  • LC 1.1M
  • WVE 948.8K
  • Earning Date
  • LC 07-29-2025
  • WVE 08-07-2025
  • Dividend Yield
  • LC N/A
  • WVE N/A
  • EPS Growth
  • LC 28.90
  • WVE N/A
  • EPS
  • LC 0.44
  • WVE N/A
  • Revenue
  • LC $1,195,590,000.00
  • WVE $104,939,000.00
  • Revenue This Year
  • LC N/A
  • WVE N/A
  • Revenue Next Year
  • LC $18.87
  • WVE $1.94
  • P/E Ratio
  • LC $25.13
  • WVE N/A
  • Revenue Growth
  • LC 8.77
  • WVE N/A
  • 52 Week Low
  • LC $7.81
  • WVE $4.25
  • 52 Week High
  • LC $18.75
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • LC 56.11
  • WVE 46.68
  • Support Level
  • LC $10.42
  • WVE $5.98
  • Resistance Level
  • LC $11.45
  • WVE $7.45
  • Average True Range (ATR)
  • LC 0.37
  • WVE 0.39
  • MACD
  • LC 0.07
  • WVE 0.01
  • Stochastic Oscillator
  • LC 73.05
  • WVE 39.73

About LC LendingClub Corporation

LendingClub Corp is a company engaged in operating an online lending marketplace platform that connects borrowers and investors for the provision of the loan facility. It offers investors access to an asset class that has generally been closed to many investors and only available on a limited basis to institutional investors. The company through the platform offers loan products such as personal, education and patient finance, small business, and auto to interested investors. It generates a majority of the revenue from the transaction fees received from the platform's role in accepting and decisioning applications on behalf of the bank partners to enable loan originations.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: